Compare SXTP & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SXTP | MNDR |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | Singapore |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.4M |
| IPO Year | N/A | 2023 |
| Metric | SXTP | MNDR |
|---|---|---|
| Price | $1.64 | $0.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | 75.3K | ★ 194.9K |
| Earning Date | 05-15-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.92 | $608,852.40 |
| Revenue Next Year | $51.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.58 |
| 52 Week High | $8.62 | $5.42 |
| Indicator | SXTP | MNDR |
|---|---|---|
| Relative Strength Index (RSI) | 59.81 | 27.72 |
| Support Level | $1.55 | N/A |
| Resistance Level | $1.84 | $0.97 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 73.68 | 15.59 |
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.